Dr. Scott J Schaeffer , MD
General Practice • Wilmington, DE
5311 Limestone Rd, Ste 201
Wilmington, DE 19808
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Scott Schaeffer is listed in NPPES under General Practice.
-
NPI assigned on February 2, 2006; this date does not establish years in practice.
-
Published CMS data list 3,727 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J0897 — Injection, denosumab, 1 mg: 1,740 service units.
- G2211 — Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's: 533 service units.
- 99214 — Established patient outpatient office visit: 418 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 19 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 4,602 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Rosuvastatin Calcium — 286 prescription fills, including refills.
- Atorvastatin Calcium — 233 prescription fills, including refills.
- Levothyroxine Sodium — 189 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 120 records in the table · Guide: How to read Medicare Part D prescriber data
-
Medicare Part B services went from 1,826 in 2020 to 3,727 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
5311 Limestone Rd
Ste 201
Wilmington, DE 19808
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Stoney Batter Family Medicine Associates Pa. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
1985
What Public CMS Data Show
General Practice: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
290 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $188,243 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $146,294 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
10,194 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$611,386 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $2,583.11 across 146 records.
By nature of payment
- Food and Beverage: $2,583.11 across 146 records.
Reporting-company totals (3 largest of 28)
- ABBVIE INC.: $327.82 across 21 records.
- AstraZeneca Pharmaceuticals LP: $259.35 across 10 records.
- Pfizer Inc.: $235.27 across 16 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
41 years (graduated 1985)
CMS Doctors and Clinicians data list 1985 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Schaeffer has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Schaeffer as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Wilmington and Delaware
Billing and prescribing volume is not a quality rating.
Medicare Part B services
Not enough clinicians listed under General Practice in Delaware have Medicare Part B data for 2024 to make a comparison.
Medicare-allowed amount
Not enough clinicians listed under General Practice in Delaware have Medicare Part B data for 2024 to make a comparison.
Paid by Medicare
Not enough clinicians listed under General Practice in Delaware have Medicare Part B data for 2024 to make a comparison.
Medicare Part D prescriptions
Not enough clinicians listed under General Practice in Delaware have Medicare Part D data for 2024 to make a comparison.
Part D drug cost
Not enough clinicians listed under General Practice in Delaware have Medicare Part D data for 2024 to make a comparison.
24 active clinicians are listed under General Practice with a practice address in Wilmington, DE (49 in Delaware).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Wilmington
4.2% of these 24 clinicians have the CMS telehealth indicator.
16.7% of these 24 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 104% from 1,826 in 2020 to 3,727 in 2024.
- 2020: 1,826
- 2021: 3,396
- 2022: 3,125
- 2023: 2,819
- 2024: 3,727
-
Medicare-allowed amount
Medicare-allowed amount increased 47% from $127,788 in 2020 to $188,243 in 2024.
- 2020: $127,788
- 2021: $216,098
- 2022: $162,743
- 2023: $161,658
- 2024: $188,243
-
Paid by Medicare
Paid by Medicare increased 40% from $104,632 in 2020 to $146,294 in 2024.
- 2020: $104,632
- 2021: $176,509
- 2022: $130,418
- 2023: $125,439
- 2024: $146,294
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 43% from 3,213 in 2020 to 4,602 in 2024.
- 2020: 3,213
- 2021: 3,658
- 2022: 4,015
- 2023: 4,202
- 2024: 4,602
-
30-day fills
30-day fills increased 50% from 6,793 in 2020 to 10,194 in 2024.
- 2020: 6,793
- 2021: 7,401
- 2022: 8,382
- 2023: 9,198
- 2024: 10,194
-
Part D drug cost
Part D drug cost increased 57% from $388,202 in 2020 to $611,386 in 2024.
- 2020: $388,202
- 2021: $361,502
- 2022: $453,941
- 2023: $639,277
- 2024: $611,386
-
Industry payments (Open Payments)
Industry payments (Open Payments) varied from year to year: $2,453.65 in 2021 and $2,583.11 in 2025.
- 2021: $2,453.65
- 2022: $1,733.78
- 2023: $2,275.76
- 2024: $2,609.97
- 2025: $2,583.11
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 146 records totaling $2,583.11.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
AIRSUPRA | General | $75.97 |
| Dexcom, Inc. |
Food and Beverage
In-kind items and services
|
Dexcom G6 Transmitter | General | $40.99 |
| Dexcom, Inc. |
Food and Beverage
In-kind items and services
|
Dexcom G6 Transmitter | General | $34.57 |
| Almatica Pharma LLC |
Food and Beverage
In-kind items and services
|
LOREEV XR | General | $32.50 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
SPRAVATO | General | $30.86 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $29.03 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
VRAYLAR | General | $28.29 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
VRAYLAR | General | $28.16 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
SHINGRIX | General | $28.14 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $27.49 |
| Lundbeck LLC |
Food and Beverage
Cash or cash equivalent
|
VYEPTI | General | $27.42 |
| Lundbeck LLC |
Food and Beverage
Cash or cash equivalent
|
VYEPTI | General | $27.24 |
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
GARDASIL 9 | General | $26.15 |
| Lundbeck LLC |
Food and Beverage
Cash or cash equivalent
|
VYEPTI | General | $26.00 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $25.93 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
KISUNLA | General | $25.89 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $25.35 |
| Lundbeck LLC |
Food and Beverage
Cash or cash equivalent
|
VYEPTI | General | $24.66 |
| Abbott Laboratories |
Food and Beverage
In-kind items and services
|
FREESTYLE LIBRE 3 | General | $24.57 |
| Abbott Laboratories |
Food and Beverage
In-kind items and services
|
FREESTYLE LIBRE 3 | General | $24.57 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $24.52 |
| Axsome Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
Auvelity | General | $24.39 |
| Abbott Laboratories |
Food and Beverage
In-kind items and services
|
CARDIOMEMS | General | $24.10 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $23.86 |
| Axsome Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
Auvelity | General | $23.84 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J0897
Injection, denosumab, 1 mg
|
1,740 | 18 | $27.24 | $25.59 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
533 | 205 | $45.00 | $15.95 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
418 | 180 | $155.00 | $124.87 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
322 | 161 | $99.89 | $88.83 |
|
G0439
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit
|
245 | 245 | $215.00 | $126.51 |
|
96372
Injection of drug or substance under skin or into muscle
|
93 | 29 | $35.00 | $14.05 |
|
J3301
Injection, triamcinolone acetonide, not otherwise specified, 10 mg
|
57 | 12 | $30.00 | $1.00 |
|
81003
Automated urinalysis test
|
49 | 33 | $26.00 | $2.20 |
|
99211
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional
|
47 | 33 | $40.00 | $22.82 |
|
93000
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report
|
36 | 35 | $75.00 | $14.03 |
|
17110
Destruction of skin growth, 1-14 growths
|
32 | 17 | $125.00 | $111.68 |
|
99496
Transitional care management services for problem of high complexity
|
29 | 25 | $320.00 | $273.63 |
|
17000
Destruction of precancer skin growth, 1 growth
|
28 | 17 | $125.00 | $64.33 |
|
17003
Destruction of precancer skin growth, 2-14 growths
|
19 | 11 | $45.00 | $6.52 |
|
87426
Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus
|
19 | 18 | $75.00 | $34.62 |
|
87428
Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza
|
18 | 16 | $75.00 | $66.74 |
|
G0180
Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and
|
16 | 14 | $60.00 | $52.56 |
|
G0402
Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment
|
14 | 14 | $215.00 | $161.98 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
12 | 12 | $240.00 | $164.14 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Rosuvastatin Calcium | Rosuvastatin Calcium | 286 | 25,820 | $6,762.31 | 82 |
| Atorvastatin Calcium | Atorvastatin Calcium | 233 | 20,125 | $4,007.95 | 61 |
| Levothyroxine Sodium | Levothyroxine Sodium | 189 | 16,442 | $3,863.44 | 49 |
| Amlodipine Besylate | Amlodipine Besylate | 157 | 13,775 | $1,569.76 | 48 |
| Lisinopril | Lisinopril | 115 | 9,995 | $924.55 | 32 |
| Losartan Potassium | Losartan Potassium | 114 | 9,360 | $1,275.69 | 29 |
| Gabapentin | Gabapentin | 100 | 4,848 | $1,675.21 | 31 |
| Zolpidem Tartrate | Zolpidem Tartrate | 91 | 5,154 | $1,355.87 | 21 |
| Omeprazole | Omeprazole | 90 | 6,870 | $1,154.87 | 24 |
| Synthroid | Levothyroxine Sodium | 86 | 6,234 | $4,577.92 | 18 |
| Oxycodone Hcl | Oxycodone Hcl | 85 | 1,868 | $2,068.93 | 11 |
| Alprazolam | Alprazolam | 76 | 2,210 | $404.74 | 21 |
| Buspirone Hcl | Buspirone Hcl | 72 | 3,290 | $1,373.32 | 18 |
| Metoprolol Succinate | Metoprolol Succinate | 71 | 5,645 | $820.21 | 21 |
| Pantoprazole Sodium | Pantoprazole Sodium | 71 | 6,024 | $1,147.28 | 20 |
| Duloxetine Hcl | Duloxetine Hcl | 70 | 6,076 | $2,349.23 | 16 |
| Jardiance | Empagliflozin | 70 | 4,523 | $85,581.78 | 17 |
| Tamsulosin Hcl | Tamsulosin Hcl | 67 | 5,582 | $1,572.28 | 23 |
| Mirtazapine | Mirtazapine | 64 | 4,540 | $1,671.75 | 16 |
| Trazodone Hcl | Trazodone Hcl | 61 | 4,089 | $248.31 | 19 |
| Metformin Hcl Er | Metformin Hcl | 58 | 5,100 | $832.87 | 15 |
| Carvedilol | Carvedilol | 56 | 4,150 | $928.44 | 15 |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 54 | 779 | $16,908.92 | 54 |
| Hydrochlorothiazide | Hydrochlorothiazide | 52 | 3,720 | $257.25 | 14 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 50 | 476 | $413.42 | 31 |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 208D00000X
A physician who specializes in the general practice of diagnosing, treating, and managing patients with a variety of illnesses and conditions.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - FAMILY PRACTICE
I20100202000434
DE
5698665479
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Stoney Batter Family Medicine Associates Pa
5311 Limestone Rd, Wilmington, DE 198081258
Phone: 3022349109
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Nurse Practitioner
Nurse Practitioner
Nurse Practitioner - Family
Family Nurse Practitioner (Certified)
Family Medicine
Doctor of Medicine (M.D.)
Family Medicine
Doctor of Osteopathic Medicine (D.O.)
Family Medicine
Doctor of Medicine (M.D.)
Family Medicine
Doctor of Medicine (M.D.)
Career & Practice History
NPI enumerated February 02, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other General Practices in Wilmington
- Dr. Caren Thompson, MD
- Dr. Dimitrios Zerefos, DO
- Dr. Wayne Garraway, DO
- Dr. Susan Otero, MD
- Dr. Deborah Consolini, MD
Mailing Address
5311 Limestone Rd, Ste 201
Wilmington, DE 19808
Phone: 3022349109